ARS Pharmaceuticals, Inc. — All Filings
494 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-26-033875 | Mar 24, 2026 | — |
| S-8 | S-8 | 0001193125-26-098444 | Mar 9, 2026 | — |
| 10-K | 10-K | 0001193125-26-097478 | Mar 9, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-097467 | Mar 9, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-015245 | Feb 13, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000722 | Jan 21, 2026 | — |
| 4 | — | 0001794284-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001951287-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001398595-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001380762-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001951238-26-000003 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001951291-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001378550-26-000003 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001380762-25-000005 | Nov 14, 2025 | Nov 13, 2025 |
| 4 | — | 0001951238-25-000005 | Nov 14, 2025 | Nov 12, 2025 |
| 4 | — | 0001580787-25-000004 | Nov 14, 2025 | Nov 12, 2025 |
| 144 | — | 0001950047-25-008816 | Nov 13, 2025 | — |
| 144 | — | 0001950047-25-008802 | Nov 12, 2025 | — |
| 144/A | — | 0001959173-25-006933 | Nov 12, 2025 | — |
| 144 | — | 0001959173-25-006931 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273111 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-273107 | Nov 10, 2025 | — |
| SCHEDULE 13D/A | — | 0001346824-25-000011 | Oct 1, 2025 | — |
| 8-K | 8-K | 0001193125-25-223228 | Sep 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-190202 | Aug 28, 2025 | Aug 13, 2025 |
| 4 | — | 0001415889-25-022761 | Aug 22, 2025 | Aug 21, 2025 |
| 4 | — | 0001415889-25-022760 | Aug 22, 2025 | Aug 21, 2025 |
| 4 | — | 0001415889-25-022638 | Aug 21, 2025 | Aug 19, 2025 |
| 144 | — | 0001950047-25-006173 | Aug 21, 2025 | — |
| 144 | — | 0001949846-25-000399 | Aug 21, 2025 | — |
| 144 | — | 0001949846-25-000386 | Aug 19, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107618 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-107617 | Aug 13, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-001146 | Aug 1, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-001080 | Jul 22, 2025 | — |
| 4 | — | 0001415889-25-019321 | Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13D/A | — | 0001193805-25-000963 | Jul 2, 2025 | — |
| 4 | — | 0001193805-25-000959 | Jul 1, 2025 | Jun 27, 2025 |
| 144 | — | 0001950047-25-004740 | Jul 1, 2025 | — |
| 4 | — | 0001415889-25-018406 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090944 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018386 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018388 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018385 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018387 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018384 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018383 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-018382 | Jun 27, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0001193125-25-148922 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001415889-25-017901 | Jun 20, 2025 | Jun 18, 2025 |